Reid Waldman

Reid Waldman began their career in 2017 as a Medical Intern at Cedars-Sinai. In 2018, they moved to The University of Connecticut Health Center, where they served as an Inaugural Clinical Trials Resident and Dermatology Resident. In 2019, Reid joined VeraDermics Inc. as the Chief Executive Officer and Chief Operating Officer.

Reid Waldman completed their Doctor of Medicine - MD degree in the 6 Year BA/MD Program at the University of Missouri-Kansas City School of Medicine from 2011 to 2017. In 2018, they obtained their Advanced Cardiac Life Support (ACLS) certification from the American Heart Association. In 2020, they were awarded the Virtual Magic Wand Scholar certification from Advancing Innovation in Dermatology, Inc.